Advances in molecular genetics of schizophrenia.
- Author:
Wu-yan CHEN
1
;
Lin HE
Author Information
1. Neuropsychiatric and Human Genetics Group, Bio-X Life Science Research Center, Shanghai Jiaotong University, Shanghai 200030, China.
- Publication Type:Journal Article
- MeSH:
Acyltransferases;
genetics;
Carrier Proteins;
genetics;
Dysbindin;
Dystrophin-Associated Proteins;
Humans;
Membrane Proteins;
genetics;
Nerve Tissue Proteins;
genetics;
Neuregulin-1;
Receptors, N-Methyl-D-Aspartate;
genetics;
Schizophrenia;
genetics
- From:
Acta Academiae Medicinae Sinicae
2005;27(3):401-407
- CountryChina
- Language:Chinese
-
Abstract:
Schizophrenia (MIM 181500) is a complex disorder affecting approximately 1% of the population worldwide. Epidemiologic evidences, together with recent linkage and association studies, have clearly demonstrated the high heritability of schizophrenia (up to 80%). Uncovering the genetic mechanism of schizophrenia has became one of the greatest challenges for both psychiatry and genetics. In recent years, remarkable advances in the genetics of this disorder has been achieved with the rapid growth of human genome information and experiment technologies. Several candidate genes within some of the best-supported linkage regions have been reported and, more importantly, replicated. Moreover, these genes present a significant connection in the signaling pathways implicated in the development of schizophrenia, especially NMDA receptor-mediated glutamate transmission. In this review, we summarize the recent advances in the genetics of schizophrenia, focusing particularly on linkage disequilibrium analysis and the latest understanding of the neurobiology of the disorder.
